eureKARE SynBio Day 2021

To culminate the inaugural eureKAWARDS Synbio pitch contest, eureKARE is pleased to invite you to participate in our event promoting Synthetic Biology. This event aims to bring together researchers, industry partners and investors in the space.

The eureKARE SynBio Day will engage you with curated talks from KOLS in the field, examine challenges in the field via a prestigious round table, over the finalists of the eureKAWARDS to pitch their projects, and allow for stakeholders to network together.

Meet our Speakers

Dr. Iordanis Arzimanoglou

EIC Programme Manager, Health and Biotechnology

Dr. David Bikard

CTO and Co-founder of Eligo Biosciences

Dr. Siyuan Chen

Chief Technology Officer, Twist Bioscience

Dr. André Choulika

CEO and Board Director of Cellectis

Dr. Antoine Danchin

Kodikos Labs, Institut Cochin, Uni. of HK Li Ka Shing Faculty of Medicine & Chairman of eureKARE SAB

Prof. Dr. Petra Schwille

Director, Cellular and Molecular Biophysics Max Planck Institute of Biochemistry

Dr. Pamela Silver

Professor of Systems Biology at Harvard Medical School & Member of eureKARE SAB

Meet our Scientific Advisory Board Members

Dr. Antoine Danchin

Kodikos Labs, Institut Cochin, Uni. of HK Li Ka Shing Faculty of Medicine & Chairman of eureKARE SAB

Dr. Joël Doré

Research Director, MetaGenoPolis, INRAE & Member of eureKARE SAB

Dr. Leroy Hood

President and Co-founder, Institute for Systems Biology, Seattle & Member of eureKARE SAB

Prof. Dr. Sven Panke

Professor, Department of Biosystems Science and Engineering, ETH Zurich & Member of eureKARE SAB

Dr. Felix Rey

Head of Virology Department, Institut Pasteur, Paris & Member of eureKARE SAB

Dr. Pamela Silver

Professor of Systems Biology at Harvard Medical School & Member of eureKARE SAB

Dr. George Weinstock

Professor and Associate Director for Microbial Genomics, The Jackson Laboratory for Genomic Medicine & Member of SAB

Schedule

NOVEMBRE 10

Welcome to our eureKARE Synbio Day

From Rodolphe Besserve, CEO of eureKARE

Stage

Nov 10 08:45AM–08:55AM UTC+1

Opening Speech from EISMEA/EIC

Jean-David Malo, Director of the Executive Agency for EIC and SMEs (EISMEA)

Stage

Nov 10 08:55AM–09:05AM UTC+1

Synthetic biology can disrupt entire industries including pharma, biotech, food, materials...

from Iordanis Arzimanoglou, PhD European Innovation Council Programme Manager

Stage

Nov 10 09:05AM–09:30AM UTC+1

Morning Speaker Session

Upcoming SynBio Research

Stage

Nov 10 09:30AM–10:30AM UTC+1

Roundtable

Major Challenges in Synthetic Biology of Today and Tomorrow

Stage

Nov 10 10:30AM–12:00PM UTC+1

Morning Keynote

Synthetic Biology Toolbox – The Future of Nucleases in Gene Editing

Stage

Nov 10 12:00PM–12:30PM UTC+1

1:1 Networking Hour

Networking

Nov 10 12:30PM–01:30PM UTC+1

eureKAWARDS Finalists Pitch Session

Stage

Nov 10 01:30PM–03:45PM UTC+1

Afternoon Speaker Session

Heavy Hitters in Synthetic Biology

Stage

Nov 10 03:45PM–04:45PM UTC+1

Coffee Break

Networking

Nov 10 04:45PM–05:00PM UTC+1

Closing Keynote

Stage

Nov 10 05:00PM–05:30PM UTC+1

Announcement of the eureKAWARDS Winner

From Serge Pampfer, CSO of eureKARE

Stage

Nov 10 05:30PM–06:00PM UTC+1

1:1 Networking Hour

Networking

Nov 10 06:00PM–07:00PM UTC+1

Partners

Potter Clarkson

Potter Clarkson will be providing IP education to all eureKAWARDS semi-finalists, as well as one-to-one IP consultancy sessions for all finalists. Potter Clarkson will be awarding the winner with its Kick-StartiP consultancy, which is designed to help businesses understand, identify, develop and document their IP strategies to start a business in the best possible way.

ERS Genomics

ERS Genomics will be offering a three-year license to the most promising CRISPR/Cas9 submission at the eureKAWARDS. This provides broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner. In addition, ERS will provide pitch training and mentoring to all semi-finalists.

Neighborhood,
VCLS' Innovation Center

Neighborhood/VCLS will provide the winner will Regulatory Strategy Sessions Package, in addition to 6 months access to their facilities in Paris